# The FARAPULSE ADVENT PIVOTAL Trial PFA System vs SOC Ablation for Paroxysmal Atrial Fibrillation

> **NCT04612244** · NA · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 706 (actual)

## Conditions studied

- Paroxysmal Atrial Fibrillation

## Interventions

- **DEVICE:** FARAPULSE Pulsed Field Ablation System
- **DEVICE:** RadioFrequency and Cryoballoon Ablation

## Key facts

- **NCT ID:** NCT04612244
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-01
- **Primary completion:** 2023-05-15
- **Final completion:** 2023-05-15
- **Target enrollment:** 706 (ACTUAL)
- **Last updated:** 2024-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04612244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04612244, "The FARAPULSE ADVENT PIVOTAL Trial PFA System vs SOC Ablation for Paroxysmal Atrial Fibrillation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04612244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*